Skip to content

Author

Idan Bergman

We have 1 of 6 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

P129 - ECE_2172 - SGLT2 inhibitors and cardiovascular effects in kidney transplant recipients with diabetes mellitus

SGLT2i use was associated with a lower risk of major cardiovascular events in KTRs with diabetes, consistent with benefits observed in non-transplant populations, and support further investigation of SGLT2i therapy in this population.

I. Dotan, Amir Polansky, Idan Bergman et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.